Results showed that interfering with the expression of CD40L in SLE mice significantly reduced the levels of IFN-γ and IL-2, while it downregulated the levels of IL-4 as well as IL-10 (Figure 2(a)). The gene discussed is IL10; the disease is systemic lupus erythematosus.